|
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study |
|
|
|
Titel: |
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study |
Auteur: |
Younes, Anas Connors, Joseph M Park, Steven I Fanale, Michelle O'Meara, Megan M Hunder, Naomi N Huebner, Dirk Ansell, Stephen M |
Verschenen in: |
Lancet oncology |
Paginering: |
Jaargang 14 (2013) nr. 13 pagina's 9 p. |
Jaar: |
2013 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|